Amgen Sees FY24 Adj. EPS $ 19.00-$20.20 vs $19.48 Est.
Portfolio Pulse from Benzinga Newsdesk
Amgen projects its FY24 adjusted earnings per share (EPS) to be in the range of $19.00 to $20.20, compared to the estimated $19.48. This forecast suggests a potential for earnings to either exceed or fall short of market expectations.
May 02, 2024 | 8:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amgen's FY24 EPS forecast ranges from $19.00 to $20.20, indicating a potential to outperform or underperform against the $19.48 estimate.
Amgen's projected EPS range for FY24 suggests uncertainty about its ability to meet or exceed market expectations. This forecast could lead to mixed reactions in the short term as investors assess the likelihood of Amgen achieving the higher end of its guidance or failing to meet the estimated $19.48. The broad range indicates potential volatility in Amgen's stock price as the market digests this information.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100